Xin Hui
Directeur/Membre du Conseil chez CHEMPARTNER PHARMATECH CO.,LTD.
Postes actifs de Xin Hui
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHEMPARTNER PHARMATECH CO.,LTD. | Directeur/Membre du Conseil | 01/01/2021 | - |
| Président | 06/06/2019 | 01/01/2021 | |
Shangpharma Corp.
 Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Directeur Général | 01/09/2007 | - |
| Président | 05/10/2010 | - | |
Kaihui Pharmaceutical (Shanghai) Co., Ltd.
 Kaihui Pharmaceutical (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Kaihui Pharmaceutical (Shanghai) Co., Ltd. was founded in 2008 and provides biomedical technology services. The private company is based in Shanghai, China. | Président | - | - |
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Président | - | - |
| Quantum Bio | Président | 01/06/2019 | - |
| Corporate Officer/Principal | 01/08/2018 | 30/05/2019 | |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/10/2022 | - |
Pandect Bioventures LP
 Pandect Bioventures LP Investment ManagersFinance Pandect Bioventures LP invests in companies located in the United States. The fund target companies operating in the fields of health technology. It provides financing for seed and early stage capital requirements. | Directeur Général | - | - |
| Yingli Pharma Ltd. | Président | - | - |
| Fondateur | - | - |
Historique de carrière de Xin Hui
Anciens postes connus de Xin Hui
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CERES VENTURES, INC. | Directeur en chef des Investissements | 01/01/2000 | 01/01/2000 |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Xin Hui
| Oregon State University | Undergraduate Degree |
| Tulane University (Louisiana) | Graduate Degree |
| New York University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 9 |
| Chine | 5 |
| Îles Cayman | 3 |
Opérationnelle
| Chairman | 7 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Consumer Services | 4 |
| Commercial Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CERES VENTURES, INC. | Health Services |
| CHEMPARTNER PHARMATECH CO.,LTD. | Commercial Services |
| Entreprise privées | 9 |
|---|---|
Shangpharma Corp.
Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Health Technology |
| China Innovation Center for Life Science | |
Shanghai ChemPartner Co., Ltd.
 Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China. | Commercial Services |
Kaihui Pharmaceutical (Shanghai) Co., Ltd.
Kaihui Pharmaceutical (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Kaihui Pharmaceutical (Shanghai) Co., Ltd. was founded in 2008 and provides biomedical technology services. The private company is based in Shanghai, China. | Commercial Services |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Finance |
| Quantum Bio | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Pandect Bioventures LP
Pandect Bioventures LP Investment ManagersFinance Pandect Bioventures LP invests in companies located in the United States. The fund target companies operating in the fields of health technology. It provides financing for seed and early stage capital requirements. | Finance |
| Yingli Pharma Ltd. |
